# State Street SPDR S&P Biotech ETF (XBI)

> Source: Nexqual · https://nexqual.com/XBI · data as of 2026-10-21 18:40 UTC · cite as "Nexqual, State Street SPDR S&P Biotech ETF (XBI), nexqual.com/XBI" · informational, not investment advice.

**Price:** USD 153.55 (+0.20% today) · US market open, as of October 21, 2026 at 18:40 UTC; quotes may be delayed. Prev close 153.24 · day 153–155.78 · 52w 106.3–169.89 · market cap null · PCX

## Key facts
- Total return with dividends: 1Y +40.8% vs S&P 500 +16.6%; 5Y +24.4% vs S&P 500 +82.7%.

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-21) | 5Y (from 2021-10-18) |
|---|---|---|
| Total return | +40.8% | +24.4% |
| S&P 500 (SPY) | +16.6% | +82.7% |
| Per year | +40.8% | +4.5% |
| Volatility (annualized) | 29.0% | 29.8% |
| Max drawdown | -14.9% (Aug 2026→Oct 2026) | -51.2% (Nov 2021→Oct 2023) |

## Peers
IBB (iShares Biotechnology ETF) USD 212.42 +0.91% · XLV (State Street Health Care Select) USD 178.81 -0.56% · XLI (State Street Industrial Select ) USD 168.6 +1.08% · XLK (State Street Technology Select ) USD 188.77 +1.79% · XLF (State Street Financial Select S) USD 56.07 +0.62%

## More
Full page: https://nexqual.com/XBI · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt

## Options: expected move (Cboe, 15-min delayed)

| Expiration | Days | ATM IV | Expected move |
|---|---|---|---|
| 2026-10-23 | 2 | 35.1% | ±2.1% |
| 2026-10-30 | 9 | 33.2% | ±4.2% |
| 2026-11-06 | 16 | 32.2% | ±5.4% |
| 2026-11-13 | 23 | 32.1% | ±6.5% |
| 2026-11-20 | 30 | 32.8% | ±7.6% |
| 2026-11-27 | 37 | 31.7% | ±8.1% |
| 2026-12-18 | 58 | 32.0% | ±10.2% |
| 2027-01-15 | 86 | 31.7% | ±12.4% |